Preventive provides a prenatal health platform that integrates next‑generation genetic sequencing, real‑time maternal health monitoring, and machine‑learning analytics to assess fetal disease risk during pregnancy.
Funding
Funding not disclosed
Founders
Product
Problem
Many genetic disorders are diagnosed only after birth, limiting treatment options and leading to lifelong health challenges for affected children. Expectant parents often lack accessible tools to assess and mitigate disease risk during pregnancy.
Solution
Preventive offers a prenatal health platform that combines comprehensive genetic screening, continuous maternal health monitoring, and predictive analytics to identify potential disease risks before birth. The system aggregates genomic data with maternal biomarkers and applies machine‑learning models to estimate the likelihood of specific conditions. Based on these risk assessments, clinicians receive actionable recommendations for early interventions, lifestyle adjustments, or enrollment in clinical trials. By delivering risk insights during pregnancy, the platform enables proactive care decisions aimed at improving long‑term health outcomes for newborns.
Target Audience
Primary customers are obstetricians, maternal‑fetal medicine specialists, and genetic counselors who provide prenatal care to expectant families at risk of hereditary conditions.
Features
- Integrated next‑generation sequencing panel covering a broad range of hereditary disease genes
- Real‑time maternal health data collection via wearable sensors and mobile health questionnaires
- Predictive analytics engine that correlates genetic variants with maternal biometrics to estimate fetal disease risk
- Clinician dashboard presenting risk scores, confidence intervals, and evidence‑based intervention pathways
- Secure, HIPAA‑compliant data storage and encrypted transmission of genomic and health information